,address1,address2,city,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,exDividendDate,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,Henley Building,8th Floor 5 Queen's Road,Central,Hong Kong,852 2514 6111,https://www.regentpac.com,Asset Management,Financial Services,"Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.",20,"{'maxAge': 1, 'name': 'Mr. Jamie Alexander  Gibson', 'age': 56, 'title': 'CEO & Exec. Director', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 1075000, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,3,0.96,0.99,0.99,1.0,0.96,0.99,0.99,1.0,1360281600,0.0,1.054429,58311,58311,47979,11597,11597,0.96,1.08,0,0,226108080,0.25,2.26,-56.106224,0.9512,1.22625,0.0,0.0,HKD,214645824,0.0,5519667,228392000,0.051,19.411766,1672444800,1703980800,1688083200,-28564000,-1.55,1:10,1465516800,-53.262,-22.229,HKG,EQUITY,0575.HK,0575.HK,REGENT PACIFIC,Regent Pacific Group Limited,1039051800,Asia/Hong_Kong,HKT,28800000,0.99,none,4969000,0.022,-9656000,70000,1.652,1.84,-4030000,0.614,-0.024,-0.74464995,-1.86315,-5320000,5.308,0.0,0.0,8.62481,USD,
1,Henley Building,8th Floor 5 Queen's Road,Central,Hong Kong,852 2514 6111,https://www.regentpac.com,Asset Management,Financial Services,"Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.",20,"{'maxAge': 1, 'name': 'Dr. Michael Grant  Wyllie BSc, D.Sc., DSc', 'age': 71, 'title': 'Co-Founder & Chief Scientific Officer', 'yearBorn': 1951, 'fiscalYear': 2014, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,3,0.96,0.99,0.99,1.0,0.96,0.99,0.99,1.0,1360281600,0.0,1.054429,58311,58311,47979,11597,11597,0.96,1.08,0,0,226108080,0.25,2.26,-56.106224,0.9512,1.22625,0.0,0.0,HKD,214645824,0.0,5519667,228392000,0.051,19.411766,1672444800,1703980800,1688083200,-28564000,-1.55,1:10,1465516800,-53.262,-22.229,HKG,EQUITY,0575.HK,0575.HK,REGENT PACIFIC,Regent Pacific Group Limited,1039051800,Asia/Hong_Kong,HKT,28800000,0.99,none,4969000,0.022,-9656000,70000,1.652,1.84,-4030000,0.614,-0.024,-0.74464995,-1.86315,-5320000,5.308,0.0,0.0,8.62481,USD,
2,Henley Building,8th Floor 5 Queen's Road,Central,Hong Kong,852 2514 6111,https://www.regentpac.com,Asset Management,Financial Services,"Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.",20,"{'maxAge': 1, 'name': 'Mr. Yui Fui  Wong', 'age': 47, 'title': 'Chief Financial Officer', 'yearBorn': 1975, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,3,0.96,0.99,0.99,1.0,0.96,0.99,0.99,1.0,1360281600,0.0,1.054429,58311,58311,47979,11597,11597,0.96,1.08,0,0,226108080,0.25,2.26,-56.106224,0.9512,1.22625,0.0,0.0,HKD,214645824,0.0,5519667,228392000,0.051,19.411766,1672444800,1703980800,1688083200,-28564000,-1.55,1:10,1465516800,-53.262,-22.229,HKG,EQUITY,0575.HK,0575.HK,REGENT PACIFIC,Regent Pacific Group Limited,1039051800,Asia/Hong_Kong,HKT,28800000,0.99,none,4969000,0.022,-9656000,70000,1.652,1.84,-4030000,0.614,-0.024,-0.74464995,-1.86315,-5320000,5.308,0.0,0.0,8.62481,USD,
3,Henley Building,8th Floor 5 Queen's Road,Central,Hong Kong,852 2514 6111,https://www.regentpac.com,Asset Management,Financial Services,"Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.",20,"{'maxAge': 1, 'name': 'Mr. Paul Eric  Jones BA, MBA', 'age': 57, 'title': 'Investment Director', 'yearBorn': 1965, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,3,0.96,0.99,0.99,1.0,0.96,0.99,0.99,1.0,1360281600,0.0,1.054429,58311,58311,47979,11597,11597,0.96,1.08,0,0,226108080,0.25,2.26,-56.106224,0.9512,1.22625,0.0,0.0,HKD,214645824,0.0,5519667,228392000,0.051,19.411766,1672444800,1703980800,1688083200,-28564000,-1.55,1:10,1465516800,-53.262,-22.229,HKG,EQUITY,0575.HK,0575.HK,REGENT PACIFIC,Regent Pacific Group Limited,1039051800,Asia/Hong_Kong,HKT,28800000,0.99,none,4969000,0.022,-9656000,70000,1.652,1.84,-4030000,0.614,-0.024,-0.74464995,-1.86315,-5320000,5.308,0.0,0.0,8.62481,USD,
4,Henley Building,8th Floor 5 Queen's Road,Central,Hong Kong,852 2514 6111,https://www.regentpac.com,Asset Management,Financial Services,"Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.",20,"{'maxAge': 1, 'name': 'Ms. Mei Yan  Lui', 'age': 47, 'title': 'Company Sec.', 'yearBorn': 1975, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,3,0.96,0.99,0.99,1.0,0.96,0.99,0.99,1.0,1360281600,0.0,1.054429,58311,58311,47979,11597,11597,0.96,1.08,0,0,226108080,0.25,2.26,-56.106224,0.9512,1.22625,0.0,0.0,HKD,214645824,0.0,5519667,228392000,0.051,19.411766,1672444800,1703980800,1688083200,-28564000,-1.55,1:10,1465516800,-53.262,-22.229,HKG,EQUITY,0575.HK,0575.HK,REGENT PACIFIC,Regent Pacific Group Limited,1039051800,Asia/Hong_Kong,HKT,28800000,0.99,none,4969000,0.022,-9656000,70000,1.652,1.84,-4030000,0.614,-0.024,-0.74464995,-1.86315,-5320000,5.308,0.0,0.0,8.62481,USD,
5,Henley Building,8th Floor 5 Queen's Road,Central,Hong Kong,852 2514 6111,https://www.regentpac.com,Asset Management,Financial Services,"Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.",20,"{'maxAge': 1, 'name': 'Prof. John Michael Fitzpatrick MCh, FRCSI, FC Urol (SA), FRCSGlas, FRCS', 'title': 'Chairman of Clinical Scientific Advisory Board', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,3,0.96,0.99,0.99,1.0,0.96,0.99,0.99,1.0,1360281600,0.0,1.054429,58311,58311,47979,11597,11597,0.96,1.08,0,0,226108080,0.25,2.26,-56.106224,0.9512,1.22625,0.0,0.0,HKD,214645824,0.0,5519667,228392000,0.051,19.411766,1672444800,1703980800,1688083200,-28564000,-1.55,1:10,1465516800,-53.262,-22.229,HKG,EQUITY,0575.HK,0575.HK,REGENT PACIFIC,Regent Pacific Group Limited,1039051800,Asia/Hong_Kong,HKT,28800000,0.99,none,4969000,0.022,-9656000,70000,1.652,1.84,-4030000,0.614,-0.024,-0.74464995,-1.86315,-5320000,5.308,0.0,0.0,8.62481,USD,
